Source: International Congress 2018 – Organoids and pluripotent stem cells



Rating:

Share or cite this content

Citations should be made in the following way:
P. Harrison (Cork, Ireland). Genome modification with CRISPR/Cas. International Congress 2018 – Organoids and pluripotent stem cells

Member's Comments

No comment yet.

Related content which might interest you: Genome wide associations Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 Microarray analysis of long non-coding RNAs in COPD Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 RNA-Seq transcriptome profiling of genes regulated by vitamin D in an asthma model Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Exome sequencing reveals immune genes as susceptibility modifiers in a1-antitrypsin deficiency Source: International Congress 2018 – Role of omics in population studies Year: 2018 Electronic antibiograms of Mycobacterium tuberculosis using Illumina whole genome sequencers data and Mykrobe software tool predictor. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Re-sequencing of PLAUR in severe asthma patients identifies novel variation Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Microarray cluster analysis reveals individual genes and biological processes associated with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 Bioinformatics approach identified of novel genes of tuberculosis susceptibility Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Analyses of genetic association and DNA methylation in the ORMDL3/GSDMB locus Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Mining common pathway deregulation profiles in lung diseases Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Gene ontology Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 meQTL analysis of asthma GWAS loci and DNA methylation Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohorts Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer Year: 2014 Pathophysiology of asthma: From endotype to phenotype Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 High-Coverage Whole Exome Sequencing Identifies Novel Frameshift Deletion of LRBA Gene in Monozygotic Twin with Common Variable Immunodeficiency. Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Asthma and myeloperoxidase gene promoter region polymorphism Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Cloning of 38Kd DNA sequence from M.tuberculosis Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003 Dual RNASeq unveils NTHi-macrophage transcriptomic changes during intracellular persistence Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Detection of first and second line drug resistance mutations from multi drug resistant mycobacterium tuberculosis strains by Ion Torrent whole genome sequencing (WGS) Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016